Calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats

Journal of Neuroscience Research

Volumn 90, Issue 11, 2012, Pages 2134-2145

  Park, Sookyoung ^a   Nozaki, Kenkichi ^a   Guyton, M Kelly ^a   Smith, Joshua A ^a   Ray, Swapan K ^b   Banik, Naren L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Calpain; Experimental autoimmune encephalomyelitis; Muscle atrophy; Nuclear factor B

Indexed keywords

ATROGIN 1; CALPAIN; CALPEPTIN; CASPASE 12; CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUSCLE RING FINGER 1 PROTEIN; PROTEIN BAX; PROTEIN BCL 2;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; LEWIS RAT; MALE; MORPHOLOGY; MUSCLE TISSUE; MYOFIBROSIS; MYOPATHY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CALPAIN; CYSTEINE PROTEINASE INHIBITORS; DIPEPTIDES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IN SITU NICK-END LABELING; MALE; MUSCLE, SKELETAL; RATS; RATS, INBRED LEW;

EID: 84866038933     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23096     Document Type: Article

References (64)

1. Allen DL, Linderman JK, Roy RR, Grindeland RE, Mukku V, Edgerton VR. 1997. Growth hormone/IGF-I and/or resistive exercise maintains myonuclear number in hindlimb unweighted muscles. J Appl Physiol 83: 1857-1861.
2. Alway SE, Degens H, Krishnamurthy G, Chaudhrai A. 2003a. Denervation stimulates apoptosis but not Id2 expression in hindlimb muscles of aged rats. J Gerontol Ser A Biol Sci Med Sci 58: 687-697.
3. Alway SE, Martyn JK, Ouyang J, Chaudhrai A, Murlasits ZS. 2003b. Id2 expression during apoptosis and satellite cell activation in unloaded and loaded quail skeletal muscles. AmJ Physiol Regul Integr Comp Physiol 284: R540-R549.
4. Ashley Z, Sutherland H, Lanmuller H, Russold MF, Unger E, Bijak M, Mayr W, Boncompagni S, Protasi F, Salmons S, Jarvis JC. 2007. Atrophy, but not necrosis, in rabbit skeletal muscle denervated for periods up to one year. Am J Physiol Cell Physiol 292: C440-C451.
5. Bartoli M, Richard I. 2005. Calpains in muscle wasting. Int J Biochem Cell Biol 37: 2115-2133.
6. Blomgren K, Hallin U, Andersson AL, Puka-Sundvall M, Bahr BA, McRae A, Saido TC, Kawashima S, Hagberg H. 1999. Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia. J Biol Chem 274: 14046-14052.
7. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ. 2001. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708.
8. Budde MD, Kim JH, Liang HF, Russell JH, Cross AH, Song SK. 2008. Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis. NMR Biomed 21: 589-597.
9. Cai D, Frantz JD, Tawa NEJr, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ, Shoelson SE. 2004. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119: 285-298.
10. Cao PR, Kim HJ, Lecker SH. 2005. Ubiquitin-protein ligases in muscle wasting. Int J Biochem Cell Biol 37: 2088-2097.
11. Cornachione AS, Benedini-Elias PC, Polizello JC, Carvalho LC, Mattiello-Sverzut AC. 2011. Characterization of fiber types in different muscles of the hindlimb in female weanling and adult Wistar rats. Acta Histochem Cytochem 44: 43-50.
12. Creus KK, De Paepe B, De Bleecker JL. 2009. Idiopathic inflammatory myopathies and the classical NF-kappaB complex: current insights and implications for therapy. Autoimmun Rev 8: 627-631.
13. Das A, Guyton MK, Matzelle DD, Ray SK, Banik NL. 2008. Time-dependent increases in protease activities for neuronal apoptosis in spinal cords of Lewis rats during development of acute experimental autoimmune encephalomyelitis. J Neurosci Res 86: 2992-3001.
14. de Haan A, van der Vliet MR, Hendriks JJ, Heijnen DA, Dijkstra CD. 2004. Changes in characteristics of rat skeletal muscle after experimental allergic encephalomyelitis. Muscle Nerve 29: 369-375.
15. Du J, Wang X, Miereles C, Bailey JL, Debigare R, Zheng B, Price SR, Mitch WE. 2004. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest 113: 115-123.
16. Dupont-Versteegden EE. 2005. Apoptosis in muscle atrophy: relevance to sarcopenia. Exp Gerontol 40: 473-481.
17. Dupont-Versteegden EE. 2006. Apoptosis in skeletal muscle and its relevance to atrophy. World J Gastroenterol 12: 7463-7466.
18. Eley HL, Tisdale MJ. 2007. Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation. J Biol Chem 282: 7087-7097.
19. Fisher M, Long RR, Drachman DA. 1983. Hand muscle atrophy in multiple sclerosis. Arch Neurol 40: 811-815.
20. Garrido C, Kroemer G. 2004. Life's smile, death's grin: vital functions of apoptosis-executing proteins. Curr Opin Cell Biol 16: 639-646.
21. Guyton MK, Wingrave JM, Yallapragada AV, Wilford GG, Sribnick EA, Matzelle DD, Tyor WR, Ray SK, Banik NL. 2005. Upregulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis. J Neurosci Res 81: 53-61.
22. Guyton MK, Das A, Samantaray S, Wallace GCt, Butler JT, Ray SK, Banik NL. 2010. Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis. J Neurosci Res 88: 2398-2408.
23. Han Y, Weinman S, Boldogh I, Walker RK, Brasier AR. 1999. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation. J Biol Chem 274: 787-794.
24. Hasselgren PO, Fischer JE. 2001. Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann Surg 233: 9-17.
25. Huang J, Forsberg NE. 1998. Role of calpain in skeletal-muscle protein degradation. Proc Natl Acad Sci U S A 95: 12100-12105.
26. Jackman RW, Kandarian SC. 2004. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 287: C834-C843.
27. Jin H, Wu Z, Tian T, Gu Y. 2001. Apoptosis in atrophic skeletal muscle induced by brachial plexus injury in rats. J Trauma 50: 31-35.
28. Keegan BM, Noseworthy JH. 2002. Multiple sclerosis. Annu Rev Med 53: 285-302.
29. Kumar A, Takada Y, Boriek AM, Aggarwal BB. 2004. Nuclear factor-kappaB: its role in health and disease. J Mol Med 82: 434-448.
30. Ladner KJ, Caligiuri MA, Guttridge DC. 2003. Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products. J Biol Chem 278: 2294-2303.
31. Leeuwenburgh C. 2003. Role of apoptosis in sarcopenia. J Gerontol Ser A Biol Sci Med Sci 58: 999-1001.
32. Leeuwenburgh C, Gurley CM, Strotman BA, Dupont-Versteegden EE. 2005. Age-related differences in apoptosis with disuse atrophy in soleus muscle. Am J Physiol Regul Integr Comp Physiol 288: R1288-R1296.
33. Li H, Malhotra S, Kumar A. 2008. Nuclear factor-kappa B signaling in skeletal muscle atrophy. J Mol Med 86: 1113-1126.
34. Liu ZQ, Kunimatsu M, Yang JP, Ozaki Y, Sasaki M, Okamoto T. 1996. Proteolytic processing of nuclear factor kappa B by calpain in vitro. FEBS Lett 385: 109-113.
35. McFarland HF, Martin R. 2007. Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 8: 913-919.
36. McKinnell IW, Rudnicki MA. 2004. Molecular mechanisms of muscle atrophy. Cell 119: 907-910.
37. Mitchell PO, Pavlath GK. 2004. Skeletal muscle atrophy leads to loss and dysfunction of muscle precursor cells. Am J Physiol Cell Physiol 287: C1753-C1762.
38. Monici MC, Aguennouz M, Mazzeo A, Messina C, Vita G. 2003. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology 60: 993-997.
39. Ng AV, Miller RG, Gelinas D, Kent-Braun JA. 2004. Functional relationships of central and peripheral muscle alterations in multiple sclerosis. Muscle Nerve 29: 843-852.
40. Nozaki K, Das A, Ray SK, Banik NL. 2010. Calpain inhibition attenuates intracellular changes in muscle cells in response to extracellular inflammatory stimulation. Exp Neurol 225: 430-435.
41. Nozaki K, Das A, Ray SK, Banik NL. 2011. Calpeptin attenuated apoptosis and intracellular inflammatory changes in muscle cells. J Neurosci Res 89: 536-543.
42. Oda A, Wakao H, Fujita H. 2002. Calpain is a signal transducer and activator of transcription (STAT) 3 and STAT5 protease. Blood 99: 1850-1852.
43. Olive M, Ferrer I. 1999. Bcl-2 and Bax protein expression in human myopathies. J Neurol Sci 164: 76-81.
44. Persinger R, Janssen-Heininger Y, Wing SS, Matthews DE, LeWinter MM, Toth MJ. 2003. Effect of heart failure on the regulation of skeletal muscle protein synthesis, breakdown, and apoptosis. Am J Physiol Endocrinol Metab 284: E1001-E1008.
45. Polfliet MM, van de Veerdonk F, Dopp EA, van Kesteren-Hendrikx EM, van Rooijen N, Dijkstra CD, van den Berg TK. 2002. The role of perivascular and meningeal macrophages in experimental allergic encephalomyelitis. J Neuroimmunol 122: 1-8.
46. Purintrapiban J, Wang MC, Forsberg NE. 2003. Degradation of sarcomeric and cytoskeletal proteins in cultured skeletal muscle cells. Comp Biochem Physiol B Biochem Mol Biol 136: 393-401.
47. Ray SK, Schaecher KE, Shields DC, Hogan EL, Banik NL. 2000. Combined TUNEL and double immunofluorescent labeling for detection of apoptotic mononuclear phagocytes in autoimmune demyelinating disease. Brain Res Brain Res Protoc 5: 305-311.
48. Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Luer W, Helwig A, Poser S. 1995. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 37: 82-88.
49. Salazar JJ, Michele DE, Brooks SV. 2010. Inhibition of calpain prevents muscle weakness and disruption of sarcomere structure during hindlimb suspension. J Appl Physiol 108: 120-127.
50. Schaecher K, Goust JM, Banik NL. 2004. The effects of calpain inhibition on IκB alpha degradation after activation of PBMCs: identification of the calpain cleavage sites. Neurochem Res 29: 1443-1451.
51. Shields DC, Banik NL. 1999. Pathophysiological role of calpain in experimental demyelination. J Neurosci Res 55: 533-541.
52. Siu PM, Alway SE. 2005. Mitochondria-associated apoptotic signalling in denervated rat skeletal muscle. J Physiol 565: 309-323.
53. Siu PM, Pistilli EE, Alway SE. 2005. Apoptotic responses to hindlimb suspension in gastrocnemius muscles from young adult and aged rats. Am J Physiol Regul Integr Comp Physiol 289: R1015-R1026.
54. Smith IJ, Lecker SH, Hasselgren PO. 2008. Calpain activity and muscle wasting in sepsis. Am J Physiol Endocrinol Metab 295: E762-E771.
55. Solomon V, Goldberg AL. 1996. Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem 271: 26690-26697.
56. Tews DS. 2002. Apoptosis and muscle fibre loss in neuromuscular disorders. Neuromusc Disord 12: 613-622.
57. Tews DS, Goebel HH, Meinck HM. 1997a. DNA-fragmentation and apoptosis-related proteins of muscle cells in motor neuron disorders. Acta Neurol Scand 96: 380-386.
58. Tews DS, Goebel HH, Schneider I, Gunkel A, Stennert E, Neiss WF. 1997b. DNA-fragmentation and expression of apoptosis-related proteins in experimentally denervated and reinnervated rat facial muscle. Neuropathol Appl Neurobiol 23: 141-149.
59. Tidball JG, Spencer MJ. 2002. Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse. J Physiol 545: 819-828.
60. Tilbery CP, Atra M, Oliveira AS, Calia LA, Schmidt B. 1989. [Histochemical study of the skeletal muscle in multiple sclerosis]. Arquivos Neuropsiquiatria 47: 337-345.
61. Vogt J, Paul F, Aktas O, Muller-Wielsch K, Dorr J, Dorr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F. 2009. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann Neurol 66: 310-322.
62. Wei W, Yang H, Cao P, Menconi M, Chamberlain C, Petkova V, Hasselgren PO. 2006. Degradation of C/EBPbeta in cultured myotubes is calpain-dependent. J Cell Physiol 208: 386-398.
63. Williams AB, Decourten-Myers GM, Fischer JE, Luo G, Sun X, Hasselgren PO. 1999. Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism. FASEB J 13: 1435-1443.
64. Xiao YY, Wang MC, Purintrapiban J, Forsberg NE. 2003. Roles of mu-calpain in cultured L8 muscle cells: application of a skeletal muscle-specific gene expression system. Comp Biochem Physiol Toxicol Pharmacol 134: 439-450.